1. Home
  2. KVHI vs TTRX Comparison

KVHI vs TTRX Comparison

Compare KVHI & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KVH Industries Inc.

KVHI

KVH Industries Inc.

HOLD

Current Price

$6.05

Market Cap

120.8M

Sector

Technology

ML Signal

HOLD

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$3.45

Market Cap

116.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KVHI
TTRX
Founded
1978
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
120.8M
116.0M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
KVHI
TTRX
Price
$6.05
$3.45
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
42.2K
17.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
29.63
N/A
EPS
N/A
N/A
Revenue
$9,622,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$14.15
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.82
N/A
52 Week Low
$4.80
$2.57
52 Week High
$7.71
$5.98

Technical Indicators

Market Signals
Indicator
KVHI
TTRX
Relative Strength Index (RSI) 41.75 42.29
Support Level $5.79 $2.64
Resistance Level $6.15 $5.12
Average True Range (ATR) 0.33 0.23
MACD 0.01 0.02
Stochastic Oscillator 22.03 29.58

Price Performance

Historical Comparison
KVHI
TTRX

About KVHI KVH Industries Inc.

KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology company focused on developing pharmaceutical and medical device products for dermatology, wound care, and infectious disease. The company's proprietary platform technology, called PermaFusion, enhances drug performance by improving the stability and bioavailability of active pharmaceutical ingredients, which allows for reduced doses and fewer side effects. Its primary development programs target skin conditions such as moderate to severe eczema and onychomycosis.

Share on Social Networks: